These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9228510

  • 1. Diabetic microangiopathy and urinary glycosaminoglycans.
    Kahaly G, Hansen C, Otto E, Förster G, Beyer J, Hommel G.
    Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
    [Abstract] [Full Text] [Related]

  • 2. Insulin-dependent diabetes mellitus and glycosaminoglycans.
    Hansen C, Irmscher AK, Kuhlemann K, Beyer J, Kahaly G.
    Horm Metab Res; 1995 Dec; 27(12):555-8. PubMed ID: 8750785
    [Abstract] [Full Text] [Related]

  • 3. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008 Dec; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 4. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P, Fresu P, Formato M, Tonolo G, Mameli M, Maioli M, Sanna GM, Cherchi GM.
    J Nephrol; 2002 Dec; 15(3):290-6. PubMed ID: 12113601
    [Abstract] [Full Text] [Related]

  • 5. Glycosaminoglycans in urine of type 1 diabetic patients.
    Sindelka G, Skrha J, Stibor V, Stolba P.
    Sb Lek; 1993 Dec; 94(1):77-80. PubMed ID: 7992002
    [Abstract] [Full Text] [Related]

  • 6. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV, Fisher EJ, McLennan SV, Yue DK, Turtle JR.
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [Abstract] [Full Text] [Related]

  • 7. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N, Hara H, Egusa G, Yamakido M.
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [Abstract] [Full Text] [Related]

  • 8. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B.
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [Abstract] [Full Text] [Related]

  • 9. Erythrocyte membrane anionic content and urinary glycosaminoglycan excretion in type 1 diabetes: association with retinopathy.
    Yenice O, Kazokoğlu H, Ozcan E, Yüksel M, Adigüzel G, Haklar G, Yavuz DG.
    Curr Eye Res; 2006 Nov; 31(11):975-81. PubMed ID: 17114123
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.
    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirer O, Parving HH.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1019-23. PubMed ID: 8671962
    [Abstract] [Full Text] [Related]

  • 11. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [Abstract] [Full Text] [Related]

  • 12. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E, Rossi L, Mariani S, Fagnani F, Quilici S, Cinapri V, Giampietro O.
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [Abstract] [Full Text] [Related]

  • 13. [Screening for microalbuminuria in diabetic patients in the primary health care system].
    Farkas K, Noll E, Jermendy G.
    Orv Hetil; 1997 Feb 23; 138(8):459-65. PubMed ID: 9139249
    [Abstract] [Full Text] [Related]

  • 14. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM.
    J Nephrol; 2005 Feb 23; 18(2):154-60. PubMed ID: 15931643
    [Abstract] [Full Text] [Related]

  • 15. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E, Seidlein I, Herfurth S, Heinke P, Chlup R, Badendick K, Strese J, Zander G, Schulz B.
    Exp Clin Endocrinol; 1992 Feb 23; 99(2):102-7. PubMed ID: 1639116
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec 23; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.